The following chemicals were used: Hydroxyurea (HU, MP Biomedicals, #102023), doxorubicin (DOX, MilliporeSigma, #25316-40-9), caffeine (Sigma-Aldrich, #C0750), ATM inhibitor (KU55933, Selleckchem, #S1092), ATR inhibitor (VE-821, Selleckchem, #S8007), cycloheximide (CHX, Fluka analytical, #01810), etoposide (Sigma-Aldrich, #E1383), camptothecin (Sigma-Aldrich, #C9911), G418 sulfate (Thermo Fisher Scientific, #10131035), MG132 (Calbiochem, #133407-82-6), cisplatin (R&D systems, #15663-27-1), propidium iodide (PI, Thermo Fisher Scientific, #P1304MP), and isopropyl-beta-D-thiogalactopyranoside (IPTG, RPI research products international, # 367-93-1).
Antibody Characterization and DNA Damage Assays
The following chemicals were used: Hydroxyurea (HU, MP Biomedicals, #102023), doxorubicin (DOX, MilliporeSigma, #25316-40-9), caffeine (Sigma-Aldrich, #C0750), ATM inhibitor (KU55933, Selleckchem, #S1092), ATR inhibitor (VE-821, Selleckchem, #S8007), cycloheximide (CHX, Fluka analytical, #01810), etoposide (Sigma-Aldrich, #E1383), camptothecin (Sigma-Aldrich, #C9911), G418 sulfate (Thermo Fisher Scientific, #10131035), MG132 (Calbiochem, #133407-82-6), cisplatin (R&D systems, #15663-27-1), propidium iodide (PI, Thermo Fisher Scientific, #P1304MP), and isopropyl-beta-D-thiogalactopyranoside (IPTG, RPI research products international, # 367-93-1).
Corresponding Organization : University of Nebraska Medical Center
Other organizations : Washington University in St. Louis
Variable analysis
- Mouse antibody to MASTL (clone 4F9, Millipore MABT372)
- Phospho-specific E6AP Ser-218 antibody generated using a synthesized peptide (SSRIGDS phospho-S QGDNNLQ)
- Hydroxyurea (HU)
- Doxorubicin (DOX)
- Caffeine
- ATM inhibitor (KU55933)
- ATR inhibitor (VE-821)
- Cycloheximide (CHX)
- Etoposide
- Camptothecin
- MG132
- Cisplatin
- Protein expression levels (α-tubulin, E6AP, HA, γ-H2AX Ser-139, phospho-ATM/ATR substrate motif, phospho-SMC1 Ser-957, phospho-CHK1 Ser-345, phospho-CHK2 Thr-68, Phospho-Aurora A (Thr288)/Aurora B (Thr232)/Aurora C (Thr198), Aurora A, Aurora B, CDK1, Cyclin B, phosphor-CDK substrates, RPA32, S5a, ubiquitin, GFP)
- G418 sulfate
- Propidium iodide (PI)
- Isopropyl-beta-D-thiogalactopyranoside (IPTG)
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!